These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31266669)

  • 1. Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
    Coronel J; Behrendt I; Bürgin T; Anderlei T; Sandig V; Reichl U; Genzel Y
    Vaccine; 2019 Nov; 37(47):7011-7018. PubMed ID: 31266669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Gränicher G; Coronel J; Pralow A; Marichal-Gallardo P; Wolff M; Rapp E; Karlas A; Sandig V; Genzel Y; Reichl U
    Vaccine; 2019 Nov; 37(47):7019-7028. PubMed ID: 31005427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbitally Shaken Single-Use Bioreactor for Animal Cell Cultivation: Fed-Batch and Perfusion Mode.
    Bürgin T; Coronel J; Hagens G; Keebler MV; Genzel Y; Reichl U; Anderlei T
    Methods Mol Biol; 2020; 2095():105-123. PubMed ID: 31858465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells.
    Genzel Y; Vogel T; Buck J; Behrendt I; Ramirez DV; Schiedner G; Jordan I; Reichl U
    Vaccine; 2014 May; 32(24):2770-81. PubMed ID: 24583003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of an acoustic settler versus a hollow fiber-based ATF technology for influenza virus production in perfusion.
    Gränicher G; Coronel J; Trampler F; Jordan I; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4877-4888. PubMed ID: 32291490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".
    Tapia F; Wohlfarth D; Sandig V; Jordan I; Genzel Y; Reichl U
    PLoS One; 2019; 14(11):e0224317. PubMed ID: 31689309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production.
    Bissinger T; Fritsch J; Mihut A; Wu Y; Liu X; Genzel Y; Tan WS; Reichl U
    Vaccine; 2019 Nov; 37(47):7003-7010. PubMed ID: 31047676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfusion Control for High Cell Density Cultivation and Viral Vaccine Production.
    Nikolay A; Bissinger T; Gränicher G; Wu Y; Genzel Y; Reichl U
    Methods Mol Biol; 2020; 2095():141-168. PubMed ID: 31858467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-cell-density cultivations to increase MVA virus production.
    Vázquez-Ramírez D; Genzel Y; Jordan I; Sandig V; Reichl U
    Vaccine; 2018 May; 36(22):3124-3133. PubMed ID: 29433897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.
    Vázquez-Ramírez D; Jordan I; Sandig V; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2019 Apr; 103(7):3025-3035. PubMed ID: 30796494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production.
    Nikolay A; Léon A; Schwamborn K; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8725-8737. PubMed ID: 30091043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells.
    Wu Y; Bissinger T; Genzel Y; Liu X; Reichl U; Tan WS
    Appl Microbiol Biotechnol; 2021 Feb; 105(4):1421-1434. PubMed ID: 33515287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.
    Tapia F; Vázquez-Ramírez D; Genzel Y; Reichl U
    Appl Microbiol Biotechnol; 2016 Mar; 100(5):2121-32. PubMed ID: 26758296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE Bioreactor™-part II: Applications for antibody production and cryopreservation.
    Clincke MF; Mölleryd C; Samani PK; Lindskog E; Fäldt E; Walsh K; Chotteau V
    Biotechnol Prog; 2013; 29(3):768-77. PubMed ID: 23436783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture.
    Petiot E; Jacob D; Lanthier S; Lohr V; Ansorge S; Kamen AA
    BMC Biotechnol; 2011 Sep; 11():84. PubMed ID: 21884612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shear contributions to cell culture performance and product recovery in ATF and TFF perfusion systems.
    Wang S; Godfrey S; Ravikrishnan J; Lin H; Vogel J; Coffman J
    J Biotechnol; 2017 Mar; 246():52-60. PubMed ID: 28159614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode.
    Coronel J; Gränicher G; Sandig V; Noll T; Genzel Y; Reichl U
    Front Bioeng Biotechnol; 2020; 8():672. PubMed ID: 32714908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of high-titer human influenza A virus with adherent and suspension MDCK cells cultured in a single-use hollow fiber bioreactor.
    Tapia F; Vogel T; Genzel Y; Behrendt I; Hirschel M; Gangemi JD; Reichl U
    Vaccine; 2014 Feb; 32(8):1003-11. PubMed ID: 24269322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.
    Lohr V; Genzel Y; Jordan I; Katinger D; Mahr S; Sandig V; Reichl U
    BMC Biotechnol; 2012 Oct; 12():79. PubMed ID: 23110398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production.
    Gränicher G; Tapia F; Behrendt I; Jordan I; Genzel Y; Reichl U
    Biotechnol J; 2021 Jan; 16(1):e2000024. PubMed ID: 32762152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.